A double-blind trial of metronidazole versus oxytetracycline therapy for rosacea

Br J Dermatol. 1980 Apr;102(4):443-5. doi: 10.1111/j.1365-2133.1980.tb06558.x.

Abstract

Forty patients with papulo-pustular rosacea were treated for 12 weeks on a random double-blind basis either with oxytetracycline 250 mg twice daily or with metronidazole 200 mg twice daily. Both drugs produced an improvement which was greater after 12 weeks than after 6 weeks, but there was no significant difference between them. Metronidazole appears to be a safe and effective drug for the treatment of rosacea.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Clinical Trials as Topic
  • Double-Blind Method
  • Humans
  • Metronidazole / therapeutic use*
  • Oxytetracycline / therapeutic use*
  • Rosacea / drug therapy*

Substances

  • Metronidazole
  • Oxytetracycline